Literature DB >> 10475324

A demonstration of the concentration and second gas effects in humans anesthetized with nitrous oxide and desflurane.

S Taheri1, E I Eger.   

Abstract

UNLABELLED: In the present study, we explored both the existence of and the basis for the concentration and second gas effects. Groups of six normocapnic patients were given one of three gas mixtures via a nonrebreathing system: 65% nitrous oxide (N2O) plus 4% desflurane; 5% N2O plus 4% desflurane; or 65% N2O plus 0.5% desflurane plus 2% xenon (Xe). End-tidal carbon dioxide (CO2) was held constant by adjustments in ventilation. Confirming the existence of the concentration effect, the end-tidal (F(A)) concentration of N2O increased toward the inspired (F(I)) concentration more rapidly (i.e., F(A)/F(I) increased more rapidly) when the inspired concentration was 65% than when it was 5%. The F(A)/F(I) for desflurane also increased more rapidly when desflurane was given with 65% rather than 5% N2O, confirming the existence of the second gas effect. The small uptake of the second gas (desflurane) did not influence its own F(A)/F(I) or that of N2O; that is, the administration of 4%, rather than 0.5%, desflurane did not increase the rate of rise of F(A)/F(I) of either N2O or desflurane. One of the bases of the concentration and second gas effects, a concentrating of residual gases, was confirmed: administration of Xe with 65% N2O produced an F(A)/F(I) for Xe that exceeded 1.0. Patient sex did not seem to influence the rate of rise of F(A)/F(I) of either N2O or desflurane. Finally, we unexpectedly found that, despite an equal solubility in blood, the rise in F(A)/F(I) for N2O exceeded that for desflurane, perhaps because of differences in tissue solubilities and intertissue diffusion. IMPLICATIONS: As predicted by the concentration and second gas effects, increasing the inspired concentration of nitrous oxide accelerated its rate of rise and the rate of rise of concurrently administered desflurane in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475324     DOI: 10.1097/00000539-199909000-00047

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 2.  [Nitrous oxide. Sense or nonsense for today's anaesthesia].

Authors:  M E Schönherr; M W Hollmann; B Graf
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

3.  Can Mathematical Modeling Explain the Measured Magnitude of the Second Gas Effect?

Authors:  Ben Korman; Ranjan K Dash; Philip J Peyton
Journal:  Anesthesiology       Date:  2018-06       Impact factor: 7.892

4.  Combining nitrous oxide with carbon dioxide decreases the time to loss of consciousness during euthanasia in mice--refinement of animal welfare?

Authors:  Aurelie A Thomas; Paul A Flecknell; Huw D R Golledge
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

5.  PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.

Authors:  David G Levitt
Journal:  BMC Anesthesiol       Date:  2002-08-15       Impact factor: 2.217

6.  Pretreatment with nitrous oxide enhances induction of anesthesia with sevoflurane: A randomized controlled trial.

Authors:  Argyro Fassoulaki; Chryssoula Staikou
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.